1. Home
  2. DFTX vs INSW Comparison

DFTX vs INSW Comparison

Compare DFTX & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definium Therapeutics Inc. Common Shares

DFTX

Definium Therapeutics Inc. Common Shares

SELL

Current Price

$30.21

Market Cap

5.9B

Sector

N/A

ML Signal

SELL

Logo International Seaways Inc.

INSW

International Seaways Inc.

SELL

Current Price

$101.98

Market Cap

5.7B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
DFTX
INSW
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
5.7B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
DFTX
INSW
Price
$30.21
$101.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
6
Target Price
$72.83
★ $131.33
AVG Volume (30 Days)
★ 1.5M
758.1K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 16.45%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 18.55
Revenue
N/A
★ $843,302,000.00
Revenue This Year
N/A
$94.05
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.50
Revenue Growth
★ N/A
N/A
52 Week Low
$14.62
$46.09
52 Week High
$49.70
$126.27

Technical Indicators

Market Signals
Indicator
DFTX
INSW
Relative Strength Index (RSI) 37.55 45.06
Support Level $20.43 $100.52
Resistance Level $38.59 $114.97
Average True Range (ATR) 2.10 4.70
MACD -0.21 -0.14
Stochastic Oscillator 3.34 42.65

Price Performance

Historical Comparison
DFTX
INSW

About DFTX Definium Therapeutics Inc. Common Shares

Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. Its fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

Share on Social Networks: